Clinical Trials
3 trialsNCT01920061 2022-09-13
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Pfizer
Phase 1 Completed
NCT00225121 2018-12-21
Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Completed
NCT00783328 2011-06-27
A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors
Pfizer
Phase 1 Completed